Testing effectiveness (Phase 2)Ended earlyNCT05761301
What this trial is testing
Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals 49